Search results
Results from the WOW.Com Content Network
Specifically, predictive genomics deals with the future phenotypic outcomes via prediction in areas such as complex multifactorial diseases in humans. [1] To date, the success of predictive genomics has been dependent on the genetic framework underlying these applications, typically explored in genome-wide association (GWA) studies. [2]
Jian Liu (born December 20, 1962) is a John & Deborah S. McNeill, Jr. Distinguished Professor at the UNC Eshelman School of Pharmacy, at the University of North Carolina at Chapel Hill. [1] He is also a founder and the chief scientific officer at Glycan Therapeutics.
Ab Initio gene prediction is an intrinsic method based on gene content and signal detection. Because of the inherent expense and difficulty in obtaining extrinsic evidence for many genes, it is also necessary to resort to ab initio gene finding, in which the genomic DNA sequence alone is systematically searched for certain tell-tale signs of protein-coding genes.
Perhaps the best-known example of computational biology, the Human Genome Project, officially began in 1990. [4] By 2003, the project had mapped around 85% of the human genome, satisfying its initial goals. [5] Work continued, however, and by 2021 level " a complete genome" was reached with only 0.3% remaining bases covered by potential issues.
Bing Liu is a Chinese-American professor of computer science who specializes in data mining, machine learning, and natural language processing. In 2002, he became a scholar at University of Illinois at Chicago . [ 1 ]
Xiaole Shirley Liu (Chinese: 刘小乐) is a computational biologist, cancer researcher, and entrepreneur. [ 4 ] [ 2 ] [ 5 ] [ 6 ] [ 7 ] She has been a Professor in the Department of Data Sciences at the Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health .
Jia Li is a Chinese-American statistician and computer scientist known for her research on image annotation and image retrieval. She is a professor of statistics and of computer science at Pennsylvania State University .
The formation of the IGI was initially announced in March 2014 as the "Innovative Genomics Initiative", a partnership between UC Berkeley and UCSF researchers and biopharmaceutical industry partners with the aim of enhancing and genome-editing technology and applying it to drug development and global health, with funding support from the Li Ka ...